Eyenovia Inc. (NASDAQ: EYEN)
$1.16
+0.0900 ( +8.41% ) 1.3M
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
Market Data
Open
$1.16
Previous close
$1.07
Volume
1.3M
Market cap
$71.89M
Day range
$1.05 - $1.19
52 week range
$0.50 - $2.57
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jul 05, 2024 |
4 | Insider transactions | 1 | Jul 03, 2024 |
8-k | 8K-related | 23 | Jul 01, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
8-k | 8K-related | 14 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |